These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradation. Aaltonen N; Lehtonen M; Varonen K; Goterris GA; Laitinen JT BMC Pharmacol; 2012 Jun; 12():7. PubMed ID: 22686545 [TBL] [Abstract][Full Text] [Related]
9. Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic deficits without alteration in circulating lysophosphatidate level. Yue J; Yokoyama K; Balazs L; Baker DL; Smalley D; Pilquil C; Brindley DN; Tigyi G Cell Signal; 2004 Mar; 16(3):385-99. PubMed ID: 14687668 [TBL] [Abstract][Full Text] [Related]
10. Signalling by lysophosphatidate and its health implications. Hemmings DG; Brindley DN Essays Biochem; 2020 Sep; 64(3):547-563. PubMed ID: 32451553 [TBL] [Abstract][Full Text] [Related]
11. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer. Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725 [TBL] [Abstract][Full Text] [Related]
12. Identification of structurally important domains of lipid phosphate phosphatase-1: implications for its sites of action. Zhang QX; Pilquil CS; Dewald J; Berthiaume LG; Brindley DN Biochem J; 2000 Jan; 345 Pt 2(Pt 2):181-4. PubMed ID: 10620492 [TBL] [Abstract][Full Text] [Related]
13. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance. Samadi N; Bekele R; Capatos D; Venkatraman G; Sariahmetoglu M; Brindley DN Biochimie; 2011 Jan; 93(1):61-70. PubMed ID: 20709140 [TBL] [Abstract][Full Text] [Related]
14. The LPA receptors. Fukushima N; Chun J Prostaglandins Other Lipid Mediat; 2001 Apr; 64(1-4):21-32. PubMed ID: 11324705 [TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent. Hooks SB; Santos WL; Im DS; Heise CE; Macdonald TL; Lynch KR J Biol Chem; 2001 Feb; 276(7):4611-21. PubMed ID: 11042183 [TBL] [Abstract][Full Text] [Related]
16. Cell-permeable ceramides inhibit the stimulation of DNA synthesis and phospholipase D activity by phosphatidate and lysophosphatidate in rat fibroblasts. Gomez-Muñoz A; Martin A; O'Brien L; Brindley DN J Biol Chem; 1994 Mar; 269(12):8937-43. PubMed ID: 8132631 [TBL] [Abstract][Full Text] [Related]
17. Exogenous phospholipase D generates lysophosphatidic acid and activates Ras, Rho and Ca2+ signaling pathways. van Dijk MC; Postma F; Hilkmann H; Jalink K; van Blitterswijk WJ; Moolenaar WH Curr Biol; 1998 Mar; 8(7):386-92. PubMed ID: 9545198 [TBL] [Abstract][Full Text] [Related]